Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Turnstone Biologics Corp. (TSBX) had Return on Tangible Equity of -225.12% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-70.84M |
|
-- |
|
-- |
|
$72.49M |
|
$-72.49M |
|
$1.69M |
|
$-70.80M |
|
$-70.80M |
|
$-70.84M |
|
$-70.84M |
|
$-70.84M |
|
$-70.84M |
|
$-72.49M |
|
$-72.52M |
|
23.04M |
|
23.04M |
|
$-3.07 |
|
$-3.07 |
|
| Balance Sheet Financials | |
$34.22M |
|
$4.17M |
|
$5.92M |
|
$40.14M |
|
$8.20M |
|
-- |
|
$0.47M |
|
$8.67M |
|
$31.47M |
|
$31.47M |
|
$31.47M |
|
23.14M |
|
| Cash Flow Statement Financials | |
$-67.44M |
|
$78.56M |
|
$0.01M |
|
$17.91M |
|
$29.04M |
|
$11.13M |
|
$3.68M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.17 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-67.64M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-225.12% |
|
|
Return on Tangible Equity |
-225.12% |
-176.48% |
|
-225.12% |
|
$1.36 |
|
$-2.94 |
|
$-2.93 |
|